{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2006-P-0025\" sorted by posted_date descending", "rows": [["FDA-2006-P-0025-0017", "FDA", "FDA-2006-P-0025", "FDA/CDER Response to Sanofi Aventis US LLC - Petition Denial", "Other", "PDN-Petition Denial", "2009-07-11T04:00:00Z", 2009, 7, "2009-07-11T04:00:00Z", null, "2009-07-11T09:05:04Z", null, 0, 0, "09000064809eede3"], ["FDA-2006-P-0025-0018", "FDA", "FDA-2006-P-0025", "ICH Harmonised Tripartite Guidelines \"Impurities in New Drug Products Q3B(R2)\" - [Sanofi-aventis U.S., LLC (sanofi-aventis) - Petition Supplement(2)]", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2009-07-11T04:00:00Z", 2009, 7, null, null, "2009-07-11T09:15:59Z", null, 0, 0, "0900006480971bb1"], ["FDA-2006-P-0025-0016", "FDA", "FDA-2006-P-0025", "Sanofi-aventis U.S., LLC (sanofi-aventis) - Petition Supplement(2)", "Other", "SUP-Supplement", "2009-05-14T04:00:00Z", 2009, 5, "2009-05-14T04:00:00Z", null, "2013-08-11T01:27:14Z", null, 0, 0, "090000648096ea74"], ["FDA-2006-P-0025-0011", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Appendix B - sanofi-aventis Analytical Study Report: Analytical Assessment of Oxaliplatin Solutions Containing Tartaric Acid", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:41Z", null, 0, 0, "0900006480441f20"], ["FDA-2006-P-0025-0007", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Reference 32 - U.S. Patent No. 6,476,068", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:37Z", null, 0, 0, "0900006480441f02"], ["FDA-2006-P-0025-0009", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Appendix A - Declarations of Professor Stephen Chaney", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:39Z", null, 0, 0, "0900006480441f1c"], ["FDA-2006-P-0025-0008", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Reference 31 - U.S. Patent No. 6,673,805", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:38Z", null, 0, 0, "0900006480441f03"], ["FDA-2006-P-0025-0015", "FDA", "FDA-2006-P-0025", "Sanofi-aventis U.S LLC - Appendix B - Supplemental Declaration of Stephen G. Chaney, Ph.D.", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T16:04:27Z", null, 0, 0, "0900006480441f34"], ["FDA-2006-P-0025-0005", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Reference 34 Mayne Pharma. Pty. LTD, et al. U.S. Patent Application No. WO/2005/020980 A1 (filed Oct. 03, 2005).", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:34Z", null, 0, 0, "0900006480441efc"], ["FDA-2006-P-0025-0010", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Appendix A - Declarations of Professor Nicholas Fartell", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:40Z", null, 0, 0, "0900006480441f1f"], ["FDA-2006-P-0025-0012", "FDA", "FDA-2006-P-0025", "Sanofi-aventis U.S LLC - Citizen Petition Supplement", "Other", "SUP-Supplement", "2008-11-17T05:00:00Z", 2008, 11, "2008-11-17T05:00:00Z", null, "2008-11-17T16:03:59Z", null, 0, 0, "0900006480441f35"], ["FDA-2006-P-0025-0006", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Reference 33 - U.S. Patent Application Publication No. US 2003/0109515 A1, Jun. 12, 2003", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T15:35:35Z", null, 0, 0, "0900006480441efd"], ["FDA-2006-P-0025-0004", "FDA", "FDA-2006-P-0025", "Sanofi-aventis US LLP - Citizen Petition", "Other", "CP-Citizen Petition", "2008-11-17T05:00:00Z", 2008, 11, "2008-11-17T05:00:00Z", null, "2009-07-11T09:01:35Z", null, 0, 0, "0900006480441f1b"], ["FDA-2006-P-0025-0014", "FDA", "FDA-2006-P-0025", "Sanofi-aventis U.S LLC - Appendix B - Supplemental Declaration of Nichola s P. Farrell, Ph.D.", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T16:04:25Z", null, 0, 0, "0900006480441f33"], ["FDA-2006-P-0025-0013", "FDA", "FDA-2006-P-0025", "Sanofi-aventis U.S LLC - U.S. Patent Application 20070054957", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-11-17T05:00:00Z", 2008, 11, null, null, "2008-11-17T16:04:24Z", null, 0, 0, "0900006480441f25"], ["FDA-2006-P-0025-0003", "FDA", "FDA-2006-P-0025", "FDA/CDER to Sanofi Aventis US LLC", "Other", "LET-Letter", "2007-06-25T04:00:00Z", 2007, 6, null, null, "2008-04-11T23:17:23Z", null, 0, 0, "0900006480441f36"], ["FDA-2006-P-0025-0002", "FDA", "FDA-2006-P-0025", "FDA/DDM to Sanofi-aventis US LLP", "Other", "ACK-Acknowledgement Letter", "2006-12-19T05:00:00Z", 2006, 12, null, null, "2008-04-11T23:17:24Z", null, 0, 0, "0900006480441f21"], ["FDA-2006-P-0025-0001", "FDA", "FDA-2006-P-0025", "FDA/DDM to Sanofi-aventis US LLP", "Other", "ACK-Acknowledgement Letter", "2006-12-19T05:00:00Z", 2006, 12, null, null, "2008-04-11T23:17:24Z", null, 0, 0, "0900006480441ef8"]], "truncated": false, "filtered_table_rows_count": 18, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2006-P-0025"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-P-0025", "results": [{"value": "FDA", "label": "FDA", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-P-0025", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-P-0025", "results": [{"value": 2008, "label": 2008, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&posted_year=2009", "selected": false}, {"value": 2006, "label": 2006, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&posted_year=2006", "selected": false}, {"value": 2007, "label": 2007, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&posted_year=2007", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0025&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2911.0761150950566, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}